Feeling Faint on Mounjaro: Why It Happens and What to Do

Dizziness and lightheadedness are listed as common side effects of tirzepatide (Mounjaro) on the NHS medicines pages and in the medicine's licensed product information.
The most frequent causes are dehydration from gastrointestinal side effects, a drop in blood pressure on standing, or simply eating too little alongside a reduced appetite.
Episodes are more likely in the first few weeks of treatment or shortly after a dose increase, when the body is still adjusting.
Severe, sudden or repeated fainting, especially alongside chest pain, palpitations or loss of consciousness, needs prompt medical assessment — call 111 or 999 as appropriate.

Feeling faint or lightheaded on Mounjaro is a recognised side effect, most often linked to reduced calorie intake, dehydration from nausea or vomiting, or blood pressure changes as the body adjusts to treatment. It is rarely serious, but it deserves attention. The NHS tirzepatide medicines page lists dizziness among the common side effects of tirzepatide, and clinical trial data from the SURMOUNT programme confirm it appears across all dose levels. If you are on Mounjaro and finding that episodes of Mounjaro-related dizziness or feeling faint are affecting your day-to-day life, the right response is never to push through quietly — it is to understand what is happening and, where necessary, talk to your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and NHS guidance say about dizziness during Mounjaro treatment

What SURMOUNT-1 data and the licensed prescribing information tell us

The SURMOUNT-1 phase 3 trial, published in the New England Journal of Medicine, followed more than 2,500 adults with obesity across 72 weeks of tirzepatide treatment. Dizziness was among the adverse events captured at every dose level tested. It appeared most often in the early weeks and after dose increases, a pattern that fits what the body does when it is eating less, absorbing fewer calories quickly and (in some participants) experiencing drops in blood pressure or blood glucose.

The prescribing information for Mounjaro reflects this: dizziness is listed as a common side effect, meaning it affects between 1 in 10 and 1 in 100 people. That range is wide, and many people taking Mounjaro never experience it at all. The point is not to alarm; it is to name something that is real and that your prescriber expects to hear about.

If you want to understand how tirzepatide works more broadly, the tirzepatide overview covers its dual GIP and GLP-1 mechanism in plain language. The short version relevant here: slowing gastric emptying and suppressing appetite both affect how the body manages fluid and energy moment to moment, and those shifts can translate into lightheadedness, particularly when standing up.

Three main reasons Mounjaro can leave you feeling faint

Most episodes of feeling faint on Mounjaro trace back to one of three things, and knowing which one applies to you shapes what to do next.

Dehydration. Nausea and vomiting (the most common Mounjaro side effects) cause fluid loss. Even mild dehydration drops blood pressure and reduces blood flow to the brain, which produces that familiar grey-edged, slightly floaty feeling before a faint. Sipping water steadily across the day (not large amounts at once, which can worsen nausea) is the practical first step. The guidance on feeling generally unwell on Mounjaro has more on managing this.

Orthostatic hypotension. This is the technical term for blood pressure dropping when you stand from sitting or lying. Mounjaro's appetite-suppressing effect means some people are eating significantly less than before treatment, which reduces circulating blood volume. The result is a momentary dip in pressure on standing, the classic head-rush followed by visual dimming. Rising slowly, pausing at the bedside before walking, and staying adequately hydrated are all that most people need.

Eating too little. This one catches people off guard. Mounjaro is very effective at reducing appetite, and some people find they are eating so little that blood glucose dips lower than usual even without diabetes. Dizziness after several hours without food, or after skipping a meal, can be the signal. Eating small, regular portions of protein-rich food matters, even when hunger has largely disappeared. The page on feeling weak during treatment covers the energy and nutrition angle in more detail.

When to treat it as urgent

The causes above are manageable. Some situations are not, and distinguishing between them matters.

Get medical help promptly (999 if there is any doubt) if fainting is sudden and without warning, is accompanied by chest pain, palpitations or irregular heartbeat, results in a fall or injury, or does not resolve quickly after sitting or lying down with legs raised. These patterns are not typical of Mounjaro's known side effect profile and need independent assessment.

The MHRA Yellow Card scheme exists so that patients can report any suspected side effect they experience, including unexpected dizziness. Doing so contributes to ongoing medicines safety monitoring in the UK. You do not need to be certain it is the medicine, suspected is enough.

If episodes are milder but recurring, your prescriber should know. A dose review, a slower titration schedule, or advice on timing your meals and fluids around your weekly injection can make a real difference. Feeling faint is not something to quietly absorb while waiting for the next check-in, it is exactly the kind of thing clinical aftercare exists for. You can reach our team if you have questions between consultations.

Practical steps that help most people

Getting through a spell of lightheadedness is largely about the fundamentals: sit or lie down immediately rather than fighting through it, keep your head below heart level if possible, drink water steadily, and eat something small if you have not eaten in a few hours. If you notice you feel unusually cold alongside the dizziness, that combination is worth mentioning to your prescriber, as both can reflect how the body is adjusting to reduced calorie intake. Avoid standing up abruptly.

It is also worth knowing that dizziness associated with Mounjaro tends to ease as the body adapts to each dose level, usually within two to three weeks. That pattern is consistent with what clinical data show. The Mounjaro treatment page has a fuller picture of what to expect across the dose schedule.

One thing worth saying plainly, because it is what many people feel at this point: if you are experiencing these episodes, it is reasonable to feel unsettled. You started treatment to improve your health, and side effects that knock you off your feet do not feel like progress. That is a fair reaction. The aim of understanding the mechanism (and knowing it is recognised, documented and usually manageable) is not to dismiss it but to give you something solid to stand on when you decide what to do next.

For those considering treatment or looking at how tirzepatide fits into broader weight management options, a prescriber-led consultation is the right starting point. If you are already on Mounjaro and struggling with side effects, that same prescriber access is what you should lean on now, and anyone thinking ahead to how Mounjaro interacts with trying to conceive will also find it worth raising with their prescriber at that same consultation. Our free consultation connects you with a GPhC-registered prescriber who reviews your case personally.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions